SERVICES

Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
Stem cells Alzheimers and stroke

Human neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease, stroke or spinal cord injury are caused by the loss of neurons and glial cells in the brain or spinal cord in the Central Nervous System (CNS). Stem cell technology has become an attractive option to investigate and treat these diseases. Several types of neurons and glial cells have successfully been generated from stem cells, which in some cases, have ameliorated some dysfunctions both in animal models of neurological disorders and in patients at clinical level. Stem cell-based therapies can be beneficial by acting through several mechanisms such as cell replacement, modulation of inflammation and trophic actions. Here we review recent and current remarkable clinical studies involving stem cell-based therapy for AD and stroke and provide an overview of the different types of stem cells available nowadays, their main properties and how they are developing as a possible therapy for neurological disorders.

Published on 09-16-2016
Authors: P. L. Martínez-Morales, A. Revilla, I. Ocaña, C. González, P. Sainz, D. McGuire, I. Liste

Comments by Dr. Calapai


This paper reviews a variety of clinical trials and studies in reference to Alzheimer's disease and stroke.
It describes that stem cells act in various ways. These include decreases in inflammation , cell replacement and trophic actions. The state of the art technique is both intravenous and nebulized/nasal approach.

Posted on 2016-09-16 09:58:59

  FB Post